Skip to main content
. 2012 Feb;56(2):909–915. doi: 10.1128/AAC.05741-11

Table 1.

Frequencies of single-step antibiotic-resistant mutants occurring in the presence and absence of tea tree oila

Organism and no. of isolates Antibiotic Fold increase in MIC Frequency of mutants in:
P valueb
Control culture with:
TTO culture with:
Antibiotic alone (treatment A) Antibiotic + TTO (treatment B) Antibiotic alone (treatment C) Antibiotic + TTO (treatment D)
S. aureus
    10 RIF 8 8.9 × 10−8 5.9 × 10−8 1.1 × 10−7 7.2 × 10−8 0.0065c
    10 MUP 8 7.3 × 10−8 2.3 × 10−8 9.9 × 10−8 3.5 × 10−8 0.0002d
    7 VAN 2 2.4 × 10−7 1.2 × 10−7 3.4 × 10−7 5.9 × 10−7 0.1268
    4 CIP 2 8.1 × 10−8 5.9 × 10−8 8.6 × 10−8 3.7 × 10−8 0.6725
E. coli
    10 RIF 8 3.7 × 10−8 2.9 × 10−8 4.3 × 10−8 3.8 × 10−8 0.2083
    9 KAN 2 3.3 × 10−6 2.0 × 10−7 2.6 × 10−6 3.1 × 10−7 <0.0001e
a

Values are the geometric means from 4 to 10 isolates. MUP, mupirocin; RIF, rifampin; VAN, vancomycin; CIP, ciprofloxacin; KAN, kanamycin; TTO, tea tree oil.

b

P values were obtained by repeated-measure one-way ANOVA.

c

Significant differences exist between treatments B and C (P < 0.01) (Bonferroni post test).

d

Significant differences exist between treatments A and B (P < 0.01), B and C (P < 0.001), and C and D (P < 0.05).

e

Significant differences exist between treatments A and B (P < 0.001), A and D (P < 0.01), B and C (P < 0.001), and C and D (P < 0.01).

HHS Vulnerability Disclosure